Number of analysed individuals | % analysed individuals | Number of HAdV-D positive individuals | % HAdV-D positive individuals | |
---|---|---|---|---|
Côte d’Ivoire | ||||
Study group | 95 | 100 | 63 | 66 |
0-5 years | 4 | 4 | 4 | 100 |
6-19 years | 7 | 7 | 5 | 71 |
20-77 years | 84 | 88 | 54 | 64 |
Male | 42 | 44 | 30 | 71 |
Female | 53 | 56 | 34 | 63 |
Asymptomatic | 45 | 47 | 15 | 33 |
Symptomatic | 50 | 53 | 35 | 70 |
Abdominal pain | 21 | 22 | 14 | 67 |
Diarrhea | 3 | 3 | 3 | 100 |
Nausea | 1 | 1 | 1 | 100 |
Ocular disease | 6 | 6 | 3 | 50 |
Fever | 10 | 11 | 9 | 90 |
Respiratory disease | 8 | 8 | 6 | 75 |
Headache | 19 | 20 | 12 | 63 |
Democratic Republic of the Congo | ||||
Study group | 105 | 100 | 50 | 48 |
0-5 years | 19 | 18 | 13 | 68 |
6-19 years | 30 | 29 | 15 | 50 |
20-78 years | 56 | 53 | 22 | 39 |
Male | 51 | 49 | 27 | 53 |
Female | 54 | 51 | 23 | 43 |
Asymptomatic | 41 | 39 | 36 | 88 |
Symptomatic | 64 | 61 | 27 | 42 |
Abdominal pain | 46 | 44 | 18 | 39 |
Diarrhea | 4 | 4 | 0 | 0 |
Nausea | 1 | 1 | 0 | 0 |
Ocular disease | 0 | 0 | 0 | 0 |
Fever | 9 | 9 | 3 | 33 |
Respiratory disease | 18 | 17 | 8 | 44 |
Headache | 14 | 13 | 6 | 43 |